Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA 2021-05-07 07:00
Asieris and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of APL-1202 and Tislelizumab 2021-05-06 20:33
DarwinHealth Announces a Research Collaboration with Bristol Myers Squibb for a Novel Cancer Target Discovery (NCTI) Initiative 2021-05-06 20:31
Moleac Pte Ltd wins SBR National Business Award for Pharmaceuticals 2021-05-06 18:12
Himalaya Therapeutics Announces Appointment of Howe Li as Chief Medical Officer 2021-05-06 10:18
Everest Medicines Receives Orphan Drug Designation from the Ministry of Food and Drug Safety in South Korea for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer 2021-05-06 08:30
Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation 2021-05-06 08:00
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19 2021-05-06 07:46
Envirotainer launches the Releye® RLP - simpler than passive, even better than active 2021-05-06 02:20
CSafe Global Providing Thermal Protection for COVID-19 Vaccine Shipments from BioNTech Facility 2021-05-05 20:00
Yangtze River Pharmaceutical Group Selects TraceLink Platform for Global Compliance 2021-05-05 20:00
Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational Study 2021-05-03 20:30
BioVaxys And BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction 2021-05-03 20:00
Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer is Expected to Alleviate the Oxygen Shortage Crisis during COVID-19 Pandemic 2021-05-01 17:17
BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH(R) Diagnostic 2021-04-29 20:56
Hilco Industrial Acquires All Machinery & Equipment from Legacy Pharmaceutical Switzerland 2021-04-29 13:04
Alphamab announced PD-L1/CTLA-4 bispecific antibody KN046 will enter new Phase II clinical trial in combination with Pfizer's Inlyta® (axitinib) 2021-04-29 08:00
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration 2021-04-29 08:00
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test" 2021-04-28 21:00
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2 2021-04-28 20:00
1 122 123 124 125 126 230